Markus Barden
Impact in
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
-
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 14
- CAR-T cell therapy research 14
-
- Immune Cell Function and Interaction 4
- T-cell and B-cell Immunology 2
- Co-authors
- Hinrich Abken (12 shared papers)Astrid Holzinger (4 shared papers)Andreas A. Hombach (3 shared papers)Agapios Sachinidis (1 shared paper)Markus Martin Chmielewski (1 shared paper)Gunter Rappl (1 shared paper)Hong Pan (5 shared papers)Dennis Christoph Harrer (7 shared papers)
In The Last Decade
Markus Barden
11 papers receiving 388 citations
Markus Barden's Hit Papers
Peers
Comparison fields: 5 of 42
- Oncology 227
- Immunology 105
- Genetics 52
- Molecular Biology 112
- Biomedical Engineering 64
Countries citing papers authored by Markus Barden
This map shows the geographic impact of Markus Barden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Barden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Barden more than expected).
Fields of papers citing papers by Markus Barden
This network shows the impact of papers produced by Markus Barden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Barden. The network helps show where Markus Barden may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Barden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy Hit paper breakdown → | 2024 | 164 |
| 2 | 2016 | 106 | |
| 3 | 2021 | 47 | |
| 4 | 2023 | 22 | |
| 5 | 2023 | 18 | |
| 6 | 2022 | 14 | |
| 7 | 2024 | 11 | |
| 8 | 2024 | 7 | |
| 9 | 2026 | 2 | |
| 10 | 2024 | 2 | |
| 11 | 2024 | 1 | |
| 12 | 2025 | 0 | |
| 13 | 2025 | 0 | |
| 14 | 2026 | 0 |
About Markus Barden
Markus Barden is a scholar working on Oncology, Immunology, Biomedical Engineering, Genetics and Physiology, having authored 14 papers that have together received 394 indexed citations. Recurring topics across this work include CAR-T cell therapy research (14 papers), Immune Cell Function and Interaction (4 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers), Virus-based gene therapy research (2 papers), Nanowire Synthesis and Applications (2 papers), T-cell and B-cell Immunology (2 papers), Nanoplatforms for cancer theranostics (1 paper) and Biomedical and Engineering Education (1 paper). The work is most often cited by research in Oncology (227 citations), Immunology (105 citations), Genetics (52 citations), Molecular Biology (112 citations) and Biomedical Engineering (64 citations). Markus Barden has collaborated with scholars based in Germany, Denmark and Hungary. Frequent co-authors include Hinrich Abken, Astrid Holzinger, Andreas A. Hombach, Agapios Sachinidis, Markus Martin Chmielewski, Gunter Rappl, Hong Pan, Dennis Christoph Harrer, György Vereb and Gerhard J. Schuetz. Their work appears in journals such as Frontiers in Immunology, Cancer Immunology Immunotherapy, Cells, Journal of Immunological Methods and Nature Chemical Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.